3:52 PM
 | 
Feb 09, 2018
 |  BC Extra  |  Politics & Policy

American College of Rheumatology recommends biosimilars for rheumatic disease

In a white paper published in Arthritis & Rheumatology, the American College of Rheumatology now recommends the use of biosimilars to treat rheumatic disease, saying they should be incorporated into the U.S. healthcare system.

The authors wrote that they reevaluated their position based on evidence from Europe, as "biosimilars have been used successfully in Europe, with rigorously acquired data supporting their broader use" and biosimilars gaining traction in the U.S....

Read the full 333 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >